QA: MARIZYME INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001413754_2023_MARIZYME_INC.pdf

Logs

Graph

Absolute values for 0001413754, MARIZYME INC.

  xvar xval
0 AssetsCurrent 1,955,303
1 IntangibleAssetsNetIncludingGoodwill 34,865,676
2 PropertyPlantAndEquipmentNet 12,545
3 remainder_Assets 1,854,114
4 LiabilitiesCurrent 2,921,767
5 LiabilitiesNoncurrent 18,343,886
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 54,319
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 3,978,826
10 remainder_Expenses 33,524,136
11 remainder_Revenues 233,485
12 remainder_NetIncome -842,074
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 38,687,638
1 Liabilities 21,265,653
2 Expenses 37,557,281
3 Revenues 233,485
4 StockholdersEquity 17,421,985
5 NetIncome -38,165,870
6 ComprehensiveNetIncome -38,165,870
7 BaseVar 49,293,066
8 EconomicCapitalRatio -0.274

Edgar->Model Mapping

Feature Distribution

Change over Time